TECNOLOGÍA PARA LA MONITORIZACIÓN Y CONTROL DE LA DIABETES

Volver

Resultados 99 resultados LastUpdate Última actualización 17/07/2018 [17:05:00] pdf PDF




Solicitudes publicadas en los últimos 60 días / Applications published in the last 60 days



previousPage Página2 de 4 nextPage   Mostrar por página


CONTINUOUS GLUCOSE MONITORING SYSTEM AND METHOD

NºPublicación: WO2018118061A1 28/06/2018

Solicitante:
SANVITA MEDICAL LLC [US]

Resumen de: WO2018118061A1

A continuous glucose monitoring system and method has an inserter assembly for inserting a sensor through the skin and into subcutaneous tissue where an inserter housing with the sensor remains on the skin after insertion, a sensor housing cover attachable to the sensor housing after insertion where the sensor housing cover has an electronic module and a battery, and an electronic device equipped with wireless communication for communicating with the electronic module of the sensor housing cover assembly, the electronic device configured for receiving input signals from the sensor, converting the input signals to analyte date, displaying the analyte data on a user interface of the electronic device, storing the data for recall, and creating and/or sending reports of the data.



traducir


 

Adjusting insulin delivery rates

NºPublicación: AU2017207484A1 28/06/2018

Solicitante:
BIGFOOT BIOMEDICAL INC

Resumen de: AU2017207484A1

A method may include generating a first plurality of insulin delivery profiles that include a first series of insulin delivery actions spanning a first time interval, projecting a first plurality of future blood glucose values for each profile of the first plurality of profiles using up-to-date blood glucose levels, selecting one of the first plurality of profiles based upon comparing future blood glucose values for each profile and target blood glucose levels, delivering insulin for a second time interval that corresponds to a first action of the first profile, generating a second plurality of insulin delivery profiles for a third time interval, projecting a second plurality of future blood glucose values for each profile of the second plurality of profiles for the third time interval, and delivering a second dose of insulin for a fourth time interval shorter than the third time interval.



traducir


 

INFUSION SYSTEMS AND RELATED PERSONALIZED ADJUSTMENT METHODS

NºPublicación: WO2018119150A1 28/06/2018

Solicitante:
MEDTRONIC MINIMED INC [US]

Resumen de: WO2018119150A1

Infusion systems, infusion devices, and related operating methods are provided. An exemplary method of operating an infusion device capable of delivering fluid to a patient involves obtaining, by a control system associated with the infusion device, an input meal indication, obtaining historical data for the patient associated with the input meal indication, determining an estimated carbohydrate amount corresponding to the input meal indication based at least in part on the historical data, determining a bolus dosage of the insulin based at least in part on the estimated carbohydrate amount, and operating an actuation arrangement of the infusion device to deliver the bolus dosage of the insulin to the patient.



traducir


 

System and method for decision support using lifestyle factors

NºPublicación: AU2017216393A1 28/06/2018

Solicitante:
DEXCOM INC

Resumen de: AU2017216393A1

Systems and methods are provided relating to open loop decision-making for management of diabetes. People with diabetes face many problems in controlling their glucose because of the complex interactions between food, insulin, exercise, stress, activity, and other physiological and environmental conditions. Established principles of management of glucose sometimes are not adequate because there is a significant amount of variability in how different conditions impact different individuals and what actions might be effective for them. Accordingly, systems and methods according to present principles minimize the impact of the vagaries of diabetes on individuals, i.e., by looking for patterns and tendencies of an individual and customizing the management to that individual. Consequently, the same reduces the uncertainty that diabetes typically is associated with and improves quality of life.



traducir


 

SYSTEMS AND METHODS FOR REFLECTANCE-BASED PROJECTION-RESOLVED OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY

NºPublicación: US2018182082A1 28/06/2018

Solicitante:
UNIV OREGON HEALTH & SCIENCE [US]

Resumen de: US2018182082A1

Embodiments provide systems and methods associated with a reflectance-based projection-resolved (rbPR) optical coherence tomography angiography (OCTA) algorithm which uses optical coherence tomography (OCT) reflectance to enhance the flow signal and suppress the projection artifacts in 3-dimensional OCTA. rbPR improves the vascular connectivity and improved the discrimination of the deeper plexus angiograms in healthy eyes, compared to prior PR-OCTA method. Additionally, rbPR removes flow projection artifacts more completely from the outer retinal slab in the eyes with age-related macular degeneration, and preserves vascular integrity of the intermediate and deep capillary plexuses in the eyes with diabetic retinopathy. Additionally, the rbPR method improves the resolution of the choriocapillaris and demonstrates details comparable to scanning electron microscopy.



traducir


 

Medical Measuring Device

NºPublicación: US2018177412A1 28/06/2018

Solicitante:
FLORE INGO [DE]

Resumen de: US2018177412A1

A measuring device for the non-invasive measurement of physiological parameters is suited to detect and localize by way of self diagnosis diseases such as, for example, inflammations, tumors or arteriosclerosis. The measuring device includes at least one optical measuring unit, an evaluation unit processing the measuring signals, and a unit for the acquisition of local tissue parameters such as fat content, water content and/or blood perfusion. The evaluation unit is designed such that at least one local metabolic parameter is determined, in particular the local oxygen consumption, from the signals furnished by the optical measuring unit and obtained from tissue parameters. Moreover, the measuring device enables the non-invasive determination of the glucose concentration.



traducir


 

SYSTEMS AND METHODS FOR PATIENT MONITORING USING AN HCP-SPECIFIC DEVICE

NºPublicación: US2018182491A1 28/06/2018

Solicitante:
DEXCOM INC [US]

Resumen de: US2018182491A1

Systems and methods disclosed provide ways for Health Care Professionals (HCPs) to be involved in initial patient system set up so that the data received is truly transformative, such that the patient not just understands what all the various numbers mean but also how the data can be used. For example, in one implementation, a CGM device is configured for use by a HCP, and includes a housing and a circuit configured to receive a signal from a transmitter coupled to an indwelling glucose sensor. A calibration module converts the received signal into clinical units. A user interface is provided that is configured to display a measured glucose concentration in the clinical units. The user interface is further configured to receive input data about a patient level, where the input data about the patient level causes the device to operate in a mode appropriate to the patient level.



traducir


 

DIABETES MANAGEMENT THERAPY ADVISOR

NºPublicación: EP3337402A1 27/06/2018

Solicitante:
ASEKO INC [US]

Resumen de: WO2017031440A1

A method (500) includes obtaining training data (310) for a population that includes training blood glucose history data (208b) including treatment doses (316, 336) of insulin administered by patients (10) of the population and one or more outcome attributes (318, 338). The method also includes identifying one or more optimum treatment doses (340) of insulin from the treatment doses yielding favorable outcome attributes. The method also includes receiving patient-state information for a treated patient, determining a next recommended treatment dose (336) of insulin for the treated patient based on one or more of the identified optimum treatment doses associated with the patients of the population having training patient-state information similar to the patient-state information for the treated patient, and transmitting the next recommended treatment dose to a portable device (110, 123, 124).



traducir


 

DATA ANALYTICS AND REPORTING OF GLUCOSE-RELATED INFORMATION

NºPublicación: EP3338208A1 27/06/2018

Solicitante:
MEDTRONIC MINIMED INC [US]

Resumen de: US2017053084A1

A computer-implemented system and related method of reporting glucose information for a user of a diabetes management device are presented here. An embodiment of the method obtains input data for the user of the diabetes management device, and identifies a glycemic response event based on an analysis of the obtained input data. The method generates a user-specific graphical representation of a glucose response to the glycemic response event. The method continues by delivering the generated graphical representation of the glucose response to a user device operated by the user.



traducir


 

Microfluidic systems for electrochemical transdermal analyte sensing using a capillary-located electrode

NºPublicación: US10004434B1 26/06/2018

Solicitante:
UNIV GEORGETOWN [US]

Resumen de: US10004434B1

A sensing device, designed to be used in contact with the skin, contains a plurality of individually controllable sites for electrochemically monitoring an analyte, such as glucose, in interstitial fluid of a user. The device includes at least a hydrophobic layer designed to contact the skin; a capillary channel providing an opening adjacent the skin; a metal electrode layer having a sensor layer applied to an edge portion thereof such that it is exposed to the interior of said capillary channel, the sensing layer being effective to measure the analyte.



traducir


 

PHOTOACOUSTIC, NONINVASIVE, AND CONTINUOUS BLOOD GLUCOSE MEASUREMENT DEVICE

NºPublicación: KR20180068658A 22/06/2018

Solicitante:
HYUNDAI MOTOR CO LTD [KR]
POSTECH ACADEMY IND FOUNDATION [KR]
KIA MOTORS CORP [KR]

Resumen de: US2018160908A1

A photoacoustic, noninvasive, and continuous blood glucose measurement device includes: a diode laser for irradiating a living body with a pulsed laser signal having a specific wavelength; and an ultrasound transducer for measuring a photoacoustic signal in a form of ultrasonic waves generated by a reaction of the living body with the pulsed laser signal.



traducir


 

SYSTEMS AND METHODS FOR REPLACING SIGNAL ARTIFACTS IN A GLUCOSE SENSOR DATA STREAM

NºPublicación: US2018168513A1 21/06/2018

Solicitante:
DEXCOM INC [US]

Resumen de: US2018168513A1

Systems and methods for minimizing or eliminating transient non-glucose related signal noise due to non-glucose rate limiting phenomenon such as ischemia, pH changes, temperatures changes, and the like. The system monitors a data stream from a glucose sensor and detects signal artifacts that have higher amplitude than electronic or diffusion-related system noise. The system replaces some or the entire data stream continually or intermittently including signal estimation methods that particularly address transient signal artifacts. The system is also capable of detecting the severity of the signal artifacts and selectively applying one or more signal estimation algorithm factors responsive to the severity of the signal artifacts, which includes selectively applying distinct sets of parameters to a signal estimation algorithm or selectively applying distinct signal estimation algorithms.



traducir


 

AUTO-CALIBRATION OF PHYSIOLOGICAL RESPONSE ESTIMATES FOR CLOSED-LOOP INSULIN DELIVERY USING PATIENT-SELECTED STANDARDIZED MEALS

NºPublicación: US2018169331A1 21/06/2018

Solicitante:
VERILY LIFE SCIENCES LLC [US]

Resumen de: US2018169331A1

Examples of determining and using physiological response estimates with glucose monitoring and insulin dosing systems and methods are disclosed. For example, one method includes receiving a selection of food items from a predefined catalog of food items as being part of a meal associated with a user profile, the catalog including nutritional information corresponding to food items in the catalog; determining nutritional information of the meal based on the nutritional information of each selected food item; receiving a notification from a user interface that a user associated with the user profile has started eating the meal; receiving successive indications of the user's glucose levels; computing a physiological response estimate associated with the user profile and the meal based on the successive indications of the user's glucose levels and the nutritional information of the meal.



traducir


 

HEALTH DEVICE FOR SMART HOME CARE

NºPublicación: WO2018107992A1 21/06/2018

Solicitante:
CHEN KAIPO [CN]

Resumen de: WO2018107992A1

A health device (1) for smart home care, comprising: a health device which is provided with a main control board (11) and which is provided in a home for use, the main control board (11) being provided, by means of electrical connection, in a plurality of modules within the health device (1); a sensing module (14) connected to the main control board (11) is further provided with a blood glucose sensing module (145), a sleep sensing module (146), and a heart sensing module (147), which use non-contact sensing to obtain detailed and accurate relevant data which is related to a target body (2), and after being fed back to the main control board (11) for determination, the same is used to establish dedicated personalized information so as to correspond to the state of the target body (2); information is transmitted to a corresponding personal clinic or hospital and home appliance (3), so as to achieve the goal of family members being able to receive perfected smart home care.



traducir


 

PROGRAMMABLE INSULIN PUMP

NºPublicación: US2018169336A1 21/06/2018

Solicitante:
TANDEM DIABETES CARE INC [US]

Resumen de: US2018169336A1

An apparatus for delivering a bolus of a medical agent to a patient. The apparatus comprises a pump mechanism, a data input device, and a processor in data communication with the keypad and arranged to control the pump mechanism. The processor is programmed to receive data specifying a bolus amount through the data port, receive data regarding duration through the data port, receive a percentage through the data port, the percentage defining a portion of the bolus amount to deliver immediately upon executing a deliver command and a remainder of the bolus amount to deliver over the duration upon executing a deliver command, and execute the deliver command thereby controlling the pump mechanism to deliver the bolus. Also a method of temporarily adjusting the delivery rate of an infusion pump. The infusion pump is programmed to deliver a basal rate. The method comprises prompting a user to select whether to enter the temporary rate as a percent of the current delivery rate or as a new delivery rate; entering into the pump a period of time having a beginning and an end; entering into the pump a temporary basal rate; and delivering the therapeutic agent at a delivery rate substantially equal to the temporary basal rate during the period of time.



traducir


 

CLOSED-LOOP INSULIN DELIVERY SYSTEM

NºPublicación: WO2018111712A1 21/06/2018

Solicitante:
VERILY LIFE SCIENCES LLC [US]

Resumen de: WO2018111712A1

Examples of determining and using physiological response estimates with glucose monitoring and insulin dosing systems and methods are disclosed. For example, one method includes receiving a selection of food items from a predefined catalog of food items as being part of a meal associated with a user profile, the catalog including nutritional information corresponding to food items in the catalog; determining nutritional information of the meal based on the nutritional information of each selected food item; receiving a notification from a user interface that a user associated with the user profile has started eating the meal; receiving successive indications of the user's glucose levels; computing a physiological response estimate associated with the user profile and the meal based on the successive indications of the user's glucose levels and the nutritional information of the meal.



traducir


 

ADENOSINE TRIPHOSPHATE-BASED BLOOD GLUCOSE MONITORING DEVICE

NºPublicación: WO2018110756A1 21/06/2018

Solicitante:
MISSIONARY BENEDICTINE SISTERS INC [KR]

Resumen de: WO2018110756A1

An ATP-based blood glucose monitoring device is provided. An ATP-based blood glucose monitoring device according to an embodiment of the present invention can comprise: a blood glucose monitoring module inserted into the body and for monitoring the blood glucose; and a bio-battery module which is inserted into the body, is for generating electrical energy on the basis of an in vivo material, and is for supplying the generated electrical energy to the blood glucose monitoring module.



traducir


 

INFUSION SYSTEMS AND RELATED PERSONALIZED BOLUSING METHODS

NºPublicación: US2018169334A1 21/06/2018

Solicitante:
MEDTRONIC MINIMED INC [US]

Resumen de: US2018169334A1

Infusion systems, infusion devices, and related operating methods are provided. An exemplary method of operating an infusion device capable of delivering fluid to a patient involves obtaining, by a control system associated with the infusion device, an input meal indication, obtaining historical data for the patient associated with the input meal indication, determining an estimated carbohydrate amount corresponding to the input meal indication based at least in part on the historical data, determining a bolus dosage of the insulin based at least in part on the estimated carbohydrate amount, and operating an actuation arrangement of the infusion device to deliver the bolus dosage of the insulin to the patient.



traducir


 

SYSTEMS AND METHODS FOR OPTIMIZING INSULIN DOSAGE

NºPublicación: US2018168448A1 21/06/2018

Solicitante:
ROCHE DIABETES CARE INC [US]

Resumen de: US2018168448A1

Embodiments of a testing method for diabetics to optimize their administered insulin dosage comprise collecting sampling sets of biomarker data, each sampling set comprising a sufficient plurality of non-adverse sampling instances and each sampling instance comprising an acceptable biomarker reading at a single point in time recorded upon compliance with adherence criteria, determining a biomarker sampling parameter from each sampling set, comparing the biomarker sampling parameter to a target biomarker range, calculating an insulin adjustment parameter associated with the biomarker sampling parameter if the biomarker sampling parameter falls outside the target biomarker range, adjusting the insulin dosage by the insulin adjustment parameter if the biomarker sampling parameter falls outside the target biomarker range and the insulin dosage does not exceed maximum dosage, and exiting the testing method if the adjusted insulin dosage is optimized. The insulin dosage is optimized when biomarker sampling parameters fall within the target biomarker range.



traducir


 

ALARMS AND ALERTS FOR MEDICATION DELIVERY DEVICES AND RELATED SYSTEMS AND METHODS

NºPublicación: WO2018111928A1 21/06/2018

Solicitante:
MAZLISH BRYAN [US]
KABEL ECKES SABINE [US]
SIEBER SHANNON [US]
BOISSIER JEFF [US]
CORTHALL GEORGE [US]
CHAN YEAN WAH [US]

Resumen de: WO2018111928A1

Systems, methods, and devices provide alarms and alerts in an on-body networked diabetes management system. Methods may include receiving glucose sensor data from a continuous glucose monitor and determining a dosage of insulin delivery based at least in part on the glucose sensor data. The method may include detecting an alarm or alert condition, and sending a wireless communication regarding the alarm or alert condition to a remote user-interface device. The method may include triggering an audible, visual, or haptic alarm or alert on the insulin delivery device unless an acknowledgement of the alarm or alert condition is received within a predetermined period of time.



traducir


 

AUGMENTED AND VIRTUAL REALITY EYEWEAR, SYSTEMS, AND METHODS FOR DELIVERING POLARIZED LIGHT AND DETERMING GLUCOSE LEVELS

NºPublicación: WO2018111449A2 21/06/2018

Solicitante:
MAGIC LEAP INC [US]

Resumen de: WO2018111449A2

Various embodiments of a user-wearable device can comprise a frame configured to mount on a user. The device can include a display attached to the frame and configured to direct virtual images to an eye of the user. The device can also include a light source configured to provide polarized light to the eye of the user and that the polarized light is configured to reflect from the eye of the user. The device can further include a light analyzer configured to determine a polarization angle rotation of the reflected light from the eye of the user such that a glucose level of the user can be determined based at least in part on the polarization angle rotation of the reflected light.



traducir


 

Analyte Detection apparatus and method of detecting an analyte

NºPublicación: GB2557311A 20/06/2018

Solicitante:
RSP SYSTEMS AS [DK]

Resumen de: GB2557311A

An analyte detection apparatus comprises a radiation source (8, fig 2) for irradiating a sample such as the skin (11, fig 2); and a receiver 10, to receive an optical Raman spectrum of radiation transmitted back from the sample (11, fig 2) in response to the received radiation from the source (8, fig 2). The receiver 10 comprises a plurality of different types of analysis device 181-4 each arranged to receive a selected part of the received optical spectrum transmitted back from the sample (11, fig 2). There may be filtration elements 141-4 to split the energy in dependence on frequency or wavelength and direct selected parts of the spectrum 161-4 to the desired analysis device 18, such that more data may be derived from the most important parts of the spectrum. The analysis devices 18 may include CCD-based and CMOS-based spectrometers, and may have different levels of resolution or signal-to-noise ratio. The apparatus may be used to determine the concentration of an analyte in the blood such as glucose, lactate, fatty acids, urea, carbamide, cholesterol, alcohol or haemoglobin.



traducir


 

METHOD FOR PREDICTING THE RISK OF COCHLEOVESTIBULAR DISORDERS DEVELOPMENT IN CHILDREN WITH TYPE I DIABETES MELLITUS

NºPublicación: RU2657943C1 18/06/2018

Solicitante:
FEDERALNOE GOSUDARSTVENNOE BYUDZHETNOE OBRAZOVATELNOE UCHREZHDENIE VYSSHEGO OBRAZOVANIYA KUBANSKIJ G [RU]

Resumen de: RU2657943C1

FIELD: medicine.SUBSTANCE: invention relates to medicine, namely, ENT diseases, and can be used for early diagnosis of cochleovestibular disorders in children with type I diabetes mellitus. Determine the thresholds of sounds perception with tonal audiometry in the range of 8,000-16,000 Hz. Perform the tabilometric examination. Reveal the phenomenon of accelerated growth of loudness (PAGL). Evaluate the stat-coordination samples together with the determination of the equilibrium function coefficient (EFC) in the Romberg test with open and closed eyes, as well as the length and area of the statokinesgram. Analyze these indicators for 7-10 days of corrective insulin therapy. When combined: raising the thresholds of the sounds perception by 20±5.6 dB at the above specified frequencies, the presence of the PAGL, and with variations in the coefficient of the equilibrium function in the Romberg test with open eyes 72.2±1.8 % to 85.3±1.4 %, reveal the cochleovestibular disorders in children at early stage in the test with eyes closed with 55.6±2.4 % to 69.4±2.7 %, increase in the length of the statokinesigram by 12.7±0.9 %, area of 10.2±1.7 %.EFFECT: method allows the early diagnosis of cochleovestibular disorders in children with type 1 diabetes by evaluating the complex of the most significant indicators.1 cl, 2 dwg, 2 ex



traducir


 

PORTABLE BLOOD MEASUREMENT APPARATUS BEING CAPABLE OF MEASUREMENT OF BLOOD SUGAR AND MANAGEMENT SYSTEM OF DIABETES MELLITUS HAVING THE SAME

NºPublicación: KR20180064854A 15/06/2018

Solicitante:
INDUSTRY ACADEMY COOPERATIVE FOUNDATION JOONGBU UNIV [KR]
JEONG SAE YI [KR]
HONG KYUNG PYO [KR]

Resumen de: KR20180064854A

당뇨병을 가진 환자들이 어느 곳에서나 자가 진단을 보다 쉽게 진행할 수 있도록 하는 휴대용 혈액 진단기 및 이를 포함하는 당뇨 관리시스템이 개시된다. 이를 위하여 케이스, 검사 스트립에 흡착된 혈액 샘플을 검사하여 혈당치를 측정할 수 있도록 혈당측정모듈이 설치된 PCB 기판, 상기 케이스의 외측면에 설치되어 측정한 혈당치를 출력하는 디스플레이부, 혈당치의 위험도를 나타내는 아이콘이 지정된 혈당치 프로그램이 저장된 저장모듈, 및 측정된 혈당치에 매칭된 아이콘을 혈당치 프로그램을 통해 추출하여 디스플레이부를 통해 출력하는 제어모듈을 포함하는 휴대용 혈액 진단기를 제공한다. 본 발명은 혈당치의 수치로 안정범위를 판단할 수 없는 사람이라도 아이콘을 통해 자신의 상태를 쉽게 판단할 수 있도록 도와주어 혈당부족이나 과잉으로 인한 쇼크를 예방할 수 있는 효과를 제공한다.



traducir


 

ANALYTE SENSOR

Nº publicación: US2018160949A1 14/06/2018

Solicitante:
DEXCOM INC [US]

Resumen de: US2018160949A1

The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.


traducir



 

previousPage Página2 de 4 nextPage Mostrar por página

Volver